These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 28463858)

  • 41. Detection of second malignancies during long-term follow-up of testicular cancer survivors.
    Buchler T; Kubankova P; Boublikova L; Donatova Z; Foldyna M; Kanakova J; Kordikova D; Kupec M; Nepomucka J; Vorsilkova E; Abrahamova J
    Cancer; 2011 Sep; 117(18):4212-8. PubMed ID: 21480199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
    Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
    van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Carboplatin-etoposide-bleomycine chemotherapy protocol in the treatment of patients with metastatic non-seminomatous germ-cell testicular tumours with good prognosis].
    Jeremić B; Djurić Lj; Djordjević S; Cirović V; Milojević Lj; Stanisavljević B; Matović M; Mijatović Lj
    Srp Arh Celok Lek; 1994; 122(9-10):257-9. PubMed ID: 17977429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of late toxicity in patients treated with cisplatin-containing combination chemotherapy for metastatic testicular cancer.
    Boyer M; Raghavan D; Harris PJ; Lietch J; Bleasel A; Walsh JC; Anderson S; Tsang CS
    J Clin Oncol; 1990 Jan; 8(1):21-6. PubMed ID: 1688614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
    Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
    Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contralateral testicular cancer in spite of TIN-negative double biopsies and interval cisplatin chemotherapy.
    Souchon R; Gertenbach U; Dieckmann KP; Hahn E; Ruwe M; Stambolis C; Loy V; Classen J
    Strahlenther Onkol; 2006 May; 182(5):289-92. PubMed ID: 16673063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Germ Cell Cancer and Multiple Relapses: Toxicity and Survival.
    Lauritsen J; Kier MG; Mortensen MS; Bandak M; Gupta R; Holm NV; Agerbaek M; Daugaard G
    J Clin Oncol; 2015 Oct; 33(28):3116-23. PubMed ID: 26240225
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extragonadal germ cell tumors: clinical presentation and management.
    Albany C; Einhorn LH
    Curr Opin Oncol; 2013 May; 25(3):261-5. PubMed ID: 23422328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cisplatin, etoposide and continuous infusion bleomycin in patients with testicular germ cell tumors: efficacy and toxicity data from a retrospective study.
    Curigliano G; Spitaleri G; Magni E; Lorizzo K; De Cobelli O; Locatelli M; Fumagalli L; Adamoli L; Cossu Rocca M; Verri E; De Pas T; Jereczek-Fossa B; Martinelli G; Goldhirsch A; Nolè F
    J Chemother; 2009 Dec; 21(6):687-92. PubMed ID: 20071294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment outcome of primary central nervous system germ cell tumors after combined therapy: a report of 23 cases].
    Yang QY; Sun XF; Huang HQ; Zhen ZJ; Xia Y; Cai QQ; Ling JY
    Ai Zheng; 2008 Apr; 27(4):438-41. PubMed ID: 18423134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.
    Bhuller KS; Zhang Y; Li D; Sehn LH; Goddard K; McBride ML; Rogers PC
    Br J Haematol; 2016 Mar; 172(5):757-68. PubMed ID: 26727959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment-related Cardiovascular Toxicity in Long-term Survivors of Testicular Cancer.
    Gugic J; Zaletel LZ; Oblak I
    Radiol Oncol; 2017 Jun; 51(2):221-227. PubMed ID: 28740458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors.
    Fosså SD; Dahl AA; Thorsen L; Hellesnes R; Kiserud CE; Tandstad T; Brydøy M; Haugnes HS; Myklebust TÅ
    J Clin Oncol; 2022 Aug; 40(23):2588-2599. PubMed ID: 35380874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Testicular germ cell tumor: Short and long-term side effects of treatment among survivors.
    Gil T; Sideris S; Aoun F; van Velthoven R; Sirtaine N; Paesmans M; Ameye L; Awada A; Devriendt D; Peltier A
    Mol Clin Oncol; 2016 Sep; 5(3):258-264. PubMed ID: 27588190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors.
    Fung C; Dinh P; Ardeshir-Rouhani-Fard S; Schaffer K; Fossa SD; Travis LB
    Adv Urol; 2018; 2018():8671832. PubMed ID: 29670654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term effects of cancer treatment and consequences of cure: cancer survivors enjoy quality of life similar to their neighbours.
    Olweny CL; Juttner CA; Rofe P; Barrow G; Esterman A; Waltham R; Abdi E; Chesterman H; Seshadri R; Sage E
    Eur J Cancer; 1993; 29A(6):826-30. PubMed ID: 8484971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cognitive function in long-term testicular cancer survivors: impact of modifiable factors.
    Dinh PC; Monahan PO; Fung C; Sesso HD; Feldman DR; Vaughn DJ; Hamilton RJ; Huddart R; Martin NE; Kollmannsberger C; Althouse S; Einhorn LH; Frisina R; Root JC; Ahles TA; Travis LB
    JNCI Cancer Spectr; 2024 Sep; 8(5):. PubMed ID: 39141447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.